There are 449 resources available
135P - Simultaneous noninvasive imaging of LAG-3 and PD-L1 for noninvasive immunotyping in lung cancers
Presenter: Lishu Zhao
Session: Poster Display session
136TiP - A cohort study on the diagnosis of benign or malignant lung nodules based on synapse 3D software AI devascularization technique
Presenter: Qiang Guo
Session: Poster Display session
138P - Faecalibacterium prausnitzii enhances tumor response to perioperative nivolumab and chemotherapy
Presenter: Alejandro Rodriguez-Festa
Session: Poster Display session
139P - Efficacy and safety of perioperative immunotherapy combinations for resectable non-small cell lung cancer: A systematic review and network meta-analysis
Presenter: Yuelin Han
Session: Poster Display session
140P - New inflammatory biomarkers in uresectable stage III NSCLC treated with radio-chemotherapy (RCT) followed by durvalumab: Preliminary results of the Neutrality trial
Presenter: Emanuela Olmetto
Session: Poster Display session
142P - AI-based approaches to predict early response in unresectable LA-NSCLC patients undergoing chemoradiation
Presenter: Carlo Greco
Session: Poster Display session
145P - I-SAbR in unresectable LA-NSCLC patients receiving durvalumab in START-NEW-ERA non-randomised phase II trial
Presenter: Paola Anselmo
Session: Poster Display session
144P - Preliminary safety and efficacy of iruplinalkib after chemoradiotherapy (CRT) in ALK/ROS1+ unresectable non-small cell lung cancer (NSCLC): Part 1 results from the INNOVATION study
Presenter: lin wang
Session: Poster Display session